News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Dr. Calvin Chao, Sr. Vice President of Medical Affairs at Tempus

Articles by Dr. Calvin Chao, Sr. Vice President of Medical Affairs at Tempus

A Conversation about Somatic, Incidental Germline, and Standalone Germline Testing in Clinical Practice

ByDr. Calvin Chao, Sr. Vice President of Medical Affairs at Tempus,Dr. Judy Garber, Chief of the Division for Cancer Genetics and Prevention at Dana-Farber Cancer

June 7th 2021

Sponsored Content by Tempus

Latest Updated Articles

A Conversation about Somatic, Incidental Germline, and Standalone Germline Testing in Clinical Practice
June 7th 2021

Trending on OncLive

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026

Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026

First-Line Zanubrutinib Is Associated With Improved Real-World Efficacy in Older Patients With CLL